ANRO - Alto Neuroscience, Inc. Sales Growth YoY (TTM)

Graphic logo of altoneuroscience.com (ANRO)

Alto Neuroscience, Inc. (ANRO) generates revenue based on the implementation of AI-driven personalized psychiatry. The TTM annual revenue growth rate visualizes market expectations, with the current value standing at 0.00. However, the absence of current sales leaves the company dependent on external financing. Meanwhile, colossal demand for neurological drugs creates a foundation for a large-scale expansion of the client base in the future.

ANRO (altoneuroscience.com) Revenue Growth YoY (Last 12 Months) history from 11/23/2025 to 11/18/2026

Alto Neuroscience - analytical breakdowns and key metrics (ANRO)

- market value and analyst target forecast:
Analysis of all company metrics:Alto Neuro - ANRO
Manufactured product of altoneuroscience.com

The defensive portfolio is based on identifying assets with sustainable scaling dynamics. This metric calculates the percentage shift in revenue over a rolling year, neutralizing short-term reporting fluctuations. For Alto Neuroscience, Inc. (ANRO), operating in the high-uncertainty zone of the CNS, this serves as a critical filter for real progress. The indicator separates random inflows from systemic business growth. By analyzing the trend of sales changes year-over-year over a 12-month period, the investor assesses the viability of the biopharmaceutical model.